 | • レポートコード：QYR2104Z1651 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、クローン病診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、医学研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・クローン病診断・治療の市場動向 ・企業の競争状況、市場シェア ・クローン病診断・治療の種類別市場規模（診断、治療） ・クローン病診断・治療の用途別市場規模（病院、医学研究機関、その他） ・クローン病診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・クローン病診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・クローン病診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クローン病診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・クローン病診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbvie、Celgene、Genetech、Johnson & Johnson、Pfizer、Prometheus Laboratories、Salix Pharmaceuticals、Takeda Pharmaceutical） ・結論 |
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
Market Analysis and Insights: Global Crohn’s Disease Diagnostic and Therapeutic Market
The global Crohn’s Disease Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn’s Disease Diagnostic and Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn’s Disease Diagnostic and Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn’s Disease Diagnostic and Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn’s Disease Diagnostic and Therapeutic market.
Global Crohn’s Disease Diagnostic and Therapeutic Scope and Market Size
Crohn’s Disease Diagnostic and Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Crohn’s Disease Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnostics
Treatment
Segment by Application
Hospital
Medical Research Institute
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostics
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2016-2027)
2.2 Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Regions
2.2.1 Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Crohn’s Disease Diagnostic and Therapeutic Industry Dynamic
2.3.1 Crohn’s Disease Diagnostic and Therapeutic Market Trends
2.3.2 Crohn’s Disease Diagnostic and Therapeutic Market Drivers
2.3.3 Crohn’s Disease Diagnostic and Therapeutic Market Challenges
2.3.4 Crohn’s Disease Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
3.4 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2020
3.5 Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Area Served
3.6 Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2022-2027)
5 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
6.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
6.2.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
6.3.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
6.4.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
7.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
7.2.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
7.3.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
7.4.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
8.2.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
8.3.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region
8.4.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
9.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
9.2.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
9.3.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
9.4.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
10.2.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
10.3.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country
10.4.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Introduction
11.1.4 Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.1.5 Abbvie Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Introduction
11.2.4 Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
11.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.3.5 Genetech Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
11.4.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
11.5.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Prometheus Laboratories
11.6.1 Prometheus Laboratories Company Details
11.6.2 Prometheus Laboratories Business Overview
11.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
11.6.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.6.5 Prometheus Laboratories Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Details
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
11.7.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
11.8.4 Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnostics
Table 3. Key Players of Treatment
Table 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2016-2021)
Table 8. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2022-2027)
Table 10. Crohn’s Disease Diagnostic and Therapeutic Market Trends
Table 11. Crohn’s Disease Diagnostic and Therapeutic Market Drivers
Table 12. Crohn’s Disease Diagnostic and Therapeutic Market Challenges
Table 13. Crohn’s Disease Diagnostic and Therapeutic Market Restraints
Table 14. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players (2016-2021)
Table 16. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2020)
Table 17. Ranking of Global Top Crohn’s Disease Diagnostic and Therapeutic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
Table 21. Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2016-2021)
Table 25. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2016-2021)
Table 29. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbvie Company Details
Table 62. Abbvie Business Overview
Table 63. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product
Table 64. Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 65. Abbvie Recent Development
Table 66. Celgene Company Details
Table 67. Celgene Business Overview
Table 68. Celgene Crohn’s Disease Diagnostic and Therapeutic Product
Table 69. Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 70. Celgene Recent Development
Table 71. Genetech Company Details
Table 72. Genetech Business Overview
Table 73. Genetech Crohn’s Disease Diagnostic and Therapeutic Product
Table 74. Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 75. Genetech Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product
Table 79. Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product
Table 84. Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Prometheus Laboratories Company Details
Table 87. Prometheus Laboratories Business Overview
Table 88. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product
Table 89. Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 90. Prometheus Laboratories Recent Development
Table 91. Salix Pharmaceuticals Company Details
Table 92. Salix Pharmaceuticals Business Overview
Table 93. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product
Table 94. Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 95. Salix Pharmaceuticals Recent Development
Table 96. Takeda Pharmaceutical Company Details
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 99. Takeda Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Diagnostics Features
Figure 3. Treatment Features
Figure 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Medical Research Institute Case Studies
Figure 7. Other Case Studies
Figure 8. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
Figure 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Crohn’s Disease Diagnostic and Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions: 2020 VS 2027
Figure 12. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2022-2027)
Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players in 2020
Figure 14. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2020
Figure 16. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2016-2021)
Figure 17. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2022-2027)
Figure 18. North America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 20. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 21. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 22. United States Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 26. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 27. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 28. Germany Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2016-2027)
Figure 38. China Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 46. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 47. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 48. Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 54. Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbvie Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 58. Celgene Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 59. Genetech Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 62. Prometheus Laboratories Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 63. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals. Market Analysis and Insights: Global Crohn…- 世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Crohn's Disease Diagnostic and Therapeutic Market The global Crohn's Disease Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…
- 世界のクローン病市場規模・現状・予測（2021年-2027年） Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Cr…
- 世界のクローン病治療市場 2021：企業別、地域別、種類・用途別 The Crohn’s Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の腸疾患検査・治療市場規模・現状・予測（2021年-2027年） Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. Ac…